Celera revokes its promise on gene patents
A US biotechnology company is attempting to patent parts of the human genome in order to profit from its research before Human Genome Project - an alliance of government and charity-funded labs - move to ensure that sequenced genetic codes are made publicly and freely available on the Internet. The Maryland-based Celera...